article Open AccessTop 1% cited
The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
The Journal of Infectious Diseases · 2009 · Vol. 199(7) · pp. 926–935
Darron R. Brown✉(Indiana University School of Medicine)Susanne K. Kjær(University of Copenhagen)Kristján Sigurðsson(Cancer Clinic)Ole‐Erik Iversen(University of Bergen)Mauricio Hernández-ÁvilaCosette M. WheelerGonzalo PérezLaura A. Koutsky(University of Washington)Eng Hseon Tay(KK Women's and Children's Hospital)Patricia García(Universidad Peruana Cayetano Heredia)Kevin A. Ault(Emory University)Suzanne M. Garland(University of Melbourne)Sepp Leodolter(Medical University of Vienna)Sven‐Eric Olsson(Karolinska Institutet)Grace Tang(University of Hong Kong)Daron G. Ferris(Augusta University)Jorma Paavonen(University of Helsinki)Marc StebenF. Xavier Bosch(Institut d'Investigació Biomédica de Bellvitge)Joakim Dillner(Lund University)Elmar A. Joura(Johns Hopkins University)Robert J. Kurman(Medical University of Warsaw)Sławomir Majewski(National Cancer Institute)Nubia Muñóz(Duke University)Evan R. MyersLuisa L. VillaFrank J. TaddeoChristine C. RobertsAmha TadesseJanine T. BryanLisa LupinacciKatherine GiacolettiHeather L. Sings(Merck (Japan))Margaret K. JamesTeresa M. HesleyEliav Barr
Abstract
ClinicalTrials.gov identifiers: NCT00092521 , NCT00092534 , and NCT00092482.
Cervical Cancer and HPV ResearchHepatitis B Virus StudiesReproductive tract infections researchMedicineCervical cancerCervical intraepithelial neoplasiaConfidence intervalHPV infectionHPV vaccinesIntraepithelial neoplasiaInternal medicineOncologyIncidence (geometry)
MeSH terms
AdolescentAdultUterine Cervical NeoplasmsFemaleHumansPapillomavirus InfectionsAlphapapillomavirusPapillomavirus VaccinesYoung Adult
Citations
627
FWCI
45.22
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
Cited by
Human Papillomavirus and Cervical Cancer
Clinical Microbiology Reviews · 2003 · 2,393 citations
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
CA A Cancer Journal for Clinicians · 2012 · 1,393 citations
A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines
Vaccine · 2012 · 739 citations
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
American Journal of Clinical Pathology · 2012 · 789 citations
References
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
The Journal of Pathology · 1999 · 8,996 citations
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
International Journal of Cancer · 2007 · 1,683 citations
Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis
British Journal of Cancer · 2003 · 686 citations
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
New England Journal of Medicine · 2003 · 6,258 citations
Classification of papillomaviruses
Virology · 2004 · 3,188 citations
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine
Vaccine · 2007 · 455 citations
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial
The Lancet Oncology · 2005 · 1,577 citations
Chapter 1: HPV in the etiology of human cancer
Vaccine · 2006 · 1,363 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.